ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,339.23
-0.37%
Dow Jones
39,065.26
-1.53%
Gold vs US Dollar
2,327.93
-2.27%
Brent Oil
81.275
-0.31%
Bitcoin
67,747.42
-1.99%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
23/05/202422:00PR Newswire (US)OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at ASCO 2024
23/05/202422:00PR Newswire (US)Abstract Published in ASCO 2024 Annual Meeting Book Showcases Validity of Belong.Life's Conversational AI Cancer Mentor 'Dave'
23/05/202422:00PR Newswire (US)THE WALLA WALLA VALLEY BECOMES FIRST CERTIFIED BLUE ZONES COMMUNITY® IN WASHINGTON
23/05/202422:00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:LLYEli Lilly and Co
23/05/202422:00PR Newswire (US)Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisNASDAQ:EPRXEupraxia Pharmaceuticals Inc
23/05/202422:00PR Newswire (US)Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisTSX:EPRXEupraxia Pharmaceuticals Inc
23/05/202422:00PR Newswire (US)New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines
23/05/202422:00PR Newswire (US)Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
23/05/202422:00PR Newswire (US)Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid CongressNASDAQ:RIGLRigel Pharmaceuticals Inc
23/05/202421:48PR Newswire (US)Diamonds de Canada Unveils the Lands Collection at JCK Show in Las Vegas
23/05/202421:37PR Newswire (US)Tanger Schedules Second Quarter 2024 Earnings Release and Conference CallNYSE:SKTTanger Inc
23/05/202421:31PR Newswire (US)Zimbis and DSN Software Announce Strategic Integration to Revolutionize Dental Inventory Management
23/05/202421:31PR Newswire (US)The FLCCC Alliance International Fellowship Program Announces 14 New Senior Fellows Across 11 Countries
23/05/202421:30PR Newswire (US)SEE Declares Quarterly Cash DividendNYSE:SEESealed Air Corporation
23/05/202421:30PR Newswire (US)Penumbra, Inc. to Present at the William Blair Growth Stock ConferenceNYSE:PENPenumbra Inc
23/05/202421:30PR Newswire (US)THE RAP SNACKS FOUNDATION EXPANDS "BOSS UP EXPERIENCE: ACTIVATE YOUR VSN" TOUR TO DALLAS, MIAMI AND NEW ORLEANS
23/05/202421:28PR Newswire (US)GLENBROOK CAPITAL MANAGEMENT RELEASES OPEN LETTER TO TEJON RANCH BOARD CALLING FOR TRANSPARENCYNYSE:TRCTejon Ranch Co
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:TRINTrinity Exploration & Production Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:WNWDWindward Ltd
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:KODKodal Minerals Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:WNWDWindward Ltd
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:GGPGreatland Gold Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:PALMPanther Metals Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:PXCPhoenix Copper Limited
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:AVCTAvacta Group Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:CTLCleantech Lithium Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:EQTEqtec Plc
23/05/202421:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:CTLCleantech Lithium Plc

Your Recent History

LSE
BP.
Bp
LSE
POS
Plexus
LSE
GCM
Gcm Resources
LSE
NG.
National Grid
LSE
BIRD
Blackbird
LSE
VAST
Vast Resources
LSE
ITV
Itv
LSE
SCE
Surface Transforms
LSE
GGP
Greatland Gold
LSE
AV.
Aviva
LSE
SOLG
Solgold
LSE
AAZ
Anglo Asian Mining
LSE
BT.A
Bt
LSE
GOLD
LSE
TRP
Tower Resources
LSE
YU.
Yu
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved